AMAG Pharmaceuticals EV/EBIT
What is the EV/EBIT of AMAG Pharmaceuticals?
The EV/EBIT of AMAG Pharmaceuticals, Inc. is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals
What does AMAG Pharmaceuticals do?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Companies with ev/ebit similar to AMAG Pharmaceuticals
- SPORTTOTAL AG has EV/EBIT of N/A
- Christopher & Banks has EV/EBIT of N/A
- MoSys has EV/EBIT of N/A
- The Victoria Mills has EV/EBIT of N/A
- Lonestar Resources US Inc has EV/EBIT of N/A
- Gold'n Futures Mineral has EV/EBIT of N/A
- AMAG Pharmaceuticals has EV/EBIT of N/A
- Conart Engineers has EV/EBIT of N/A
- Asia-Pac Investment has EV/EBIT of N/A
- St. James Gold has EV/EBIT of N/A
- Anika Therapeutics has EV/EBIT of N/A
- Dyadic International has EV/EBIT of N/A
- UTStarcom Corp has EV/EBIT of N/A